Title: A phase I study of rebeccamycin analog in combination with oxaliplatin in patients with refractory solid tumors.
Journal: Investigational new drugs 20110201
Title: Phase II and pharmacokinetic trial of rebeccamycin analog in advanced biliary cancers.
Journal: Cancer chemotherapy and pharmacology 20091201
Title: Becatecarin (rebeccamycin analog, NSC 655649) is a transport substrate and induces expression of the ATP-binding cassette transporter, ABCG2, in lung carcinoma cells.
Journal: Cancer chemotherapy and pharmacology 20090801
Title: Phase 1 study of XL119, a rebeccamycin analog, in patients with refractory hematologic malignancies.
Journal: Cancer 20080715
Title: A phase II trial of rebeccamycin analogue (NSC #655649) in children with solid tumors: a Children's Oncology Group study.
Journal: Pediatric blood & cancer 20080301
Title: Phase I and pharmacokinetic study of sequences of the rebeccamycin analogue NSC 655649 and cisplatin in patients with advanced solid tumors.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20051215
Title: Becatecarin (Helsinn Healthcare).
Journal: IDrugs : the investigational drugs journal 20051001
Title: A phase II study of rebeccamycin analog (NSC-655649) in metastatic renal cell cancer.
Journal: Investigational new drugs 20031101
Title: Rebeccamycin analogues bearing amine substituents or other groups on the sugar moiety.
Journal: Bioorganic & medicinal chemistry 20030815
Title: Phase I trial of rebeccamycin analog (NSC #655649) in children with refractory solid tumors: a pediatric oncology group study.
Journal: Journal of pediatric hematology/oncology 20030701
Title: A phase II study of rebeccamycin analog NSC 655649 in patients with metastatic colorectal cancer.
Journal: Investigational new drugs 20030201
Title: Phase I clinical and pharmacokinetic study of NSC 655649, a rebeccamycin analogue, given in both single-dose and multiple-dose formats.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20020701
Title: Discovery of antitumor indolocarbazoles: rebeccamycin, NSC 655649, and fluoroindolocarbazoles.
Journal: Current medicinal chemistry. Anti-cancer agents 20020301
Title: Phase I and pharmacokinetic study of NSC 655649, a rebeccamycin analog with topoisomerase inhibitory properties.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20010601
Title: Phase I clinical and pharmacokinetic study of rebeccamycin analog NSC 655649 given daily for five consecutive days.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20010415
